These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Studies on platelet adhesiveness. II. On various diseases]. Nishino T Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):672-80. PubMed ID: 5292461 [No Abstract] [Full Text] [Related]
25. [Antithrombin activity in arteriosclerotic changes of the blood vessels and venous obstruction]. Blatný J; Fischerová E Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):285-91. PubMed ID: 4106020 [No Abstract] [Full Text] [Related]
26. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716 [TBL] [Abstract][Full Text] [Related]
27. [The fibronectin level in children with diabetes mellitus]. Popova VA; Ostashevskaia MI; Afonin AA; Bryskina AE Probl Endokrinol (Mosk); 1989; 35(3):43-4. PubMed ID: 2762263 [TBL] [Abstract][Full Text] [Related]
28. Platelet survival studies in man. With special reference to thrombosis and atherosclerosis. Abrahamsen AF Scand J Haematol Suppl; 1968; 3():1-53. PubMed ID: 5253463 [No Abstract] [Full Text] [Related]
30. [Relation between the hemostatic process and thrombosis. A clinical problem]. Ponari O; Dettori AG Recenti Prog Med; 1968 Sep; 45(3):259-82. PubMed ID: 4916345 [No Abstract] [Full Text] [Related]
31. Plasminogen activator inhibitor in plasma and arteriosclerosis. Matsuda T; Morishita E; Jokaji H; Saito M; Kumabashiri I; Akakura H; Uotani C; Yamazaki M Ann N Y Acad Sci; 1995 Jan; 748():394-8. PubMed ID: 7695181 [No Abstract] [Full Text] [Related]
32. [New method for determination of serum lipid-iodine number]. Medgyesi G; Szirmai E Pharmazie; 1969 Dec; 24(12):749-50. PubMed ID: 5379018 [No Abstract] [Full Text] [Related]
33. [Triglycerides: interpretation of the test results]. Fukui I Nihon Rinsho; 1969 Mar; ():Suppl:792-801. PubMed ID: 4948297 [No Abstract] [Full Text] [Related]
34. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease]. Grifò G; Lo Presti R; Montana M; Canino B; Caimi G Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474 [TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of the thrombelastogram (TEG) in arteriosclerosis and hypertension disease]. Amanasob K Folia Med (Plovdiv); 1969; 11(2):150-5. PubMed ID: 4988575 [No Abstract] [Full Text] [Related]
36. [Blood lipoproteins and cerebral infarct. II. Dyslipoproteinemia]. Kelová J; Bartko D Cesk Neurol Neurochir; 1986 May; 49(3):162-6. PubMed ID: 3719792 [No Abstract] [Full Text] [Related]
37. [The content of ceruloplasmin, fibronectin and selenium in the blood of patients with an acute myocardial infarct]. Chaialo PP; Solov'ev AV; Ena IaM; Soroka VR; Ermolin GA; Padalka MN; Chobot'ko GM; Shekhter IR Lik Sprava; 1992 Mar; (3):15-7. PubMed ID: 1413675 [TBL] [Abstract][Full Text] [Related]
39. [Various aspects of blood platelet function of patients who have sustained an ischemic stroke or myocardial infarct and of their relatives]. Davidenkova EF; Kolosova NN; Liberman IS; Grigor'eva VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):3-7. PubMed ID: 7073863 [TBL] [Abstract][Full Text] [Related]
40. [Primary hyperlipemia: intra-platelet and serum NEFA. Their relation to hypercoagulability]. Yañez-Polo MA; Muñoz-González J; C-Soriguer-Escofet F; Causse-Prado M; Lissen-Otero E; León-Castro J Minerva Med; 1974 Apr; 65(25):1329-39. PubMed ID: 4849473 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]